Precision BioSciences to Present at Upcoming Scientific Conferences
September 04, 2019 06:30 ET
|
Precision Biosciences
DURHAM, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its...
Precision BioSciences to Present at Upcoming Investor Conferences
August 28, 2019 06:30 ET
|
Precision Biosciences
DURHAM, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its...
Precision BioSciences Reports Second Quarter 2019 Financial Results and Highlights Ongoing Operational Progress
August 14, 2019 16:30 ET
|
Precision Biosciences
DURHAM, N.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its...
Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States
July 18, 2019 06:30 ET
|
Precision Biosciences
DURHAM, N.C., July 18, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary...
Elo Life Systems’ Mario G. Pennisi Awarded BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture at BIO World Congress
July 10, 2019 15:00 ET
|
Precision Biosciences
DURHAM, N.C. and BRISBANE, Australia, July 10, 2019 (GLOBE NEWSWIRE) -- Elo Life Systems Inc. (“Elo”), a wholly owned subsidiary of Precision BioSciences, Inc. (Nasdaq: DTIL) announced today that...
Precision BioSciences Appoints Dario Scimeca as General Counsel
June 12, 2019 06:30 ET
|
Precision Biosciences
DURHAM, N.C., June 12, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS®...
Precision BioSciences to Present at Upcoming Investor Conferences
May 29, 2019 06:30 ET
|
Precision Biosciences
DURHAM, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS®...
Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer
May 14, 2019 06:30 ET
|
Precision Biosciences
DURHAM, N.C., May 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS® genome...
Precision BioSciences Announces Presentations at the 14th Annual Terrapinn World Advanced Therapies & Regenerative Medicine Congress & Expo 2019
May 09, 2019 06:30 ET
|
Precision Biosciences
DURHAM, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS® genome...
Precision BioSciences Reports First Quarter 2019 Financial Results
April 29, 2019 16:15 ET
|
Precision Biosciences
DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, a genome editing company dedicated to improving life (Nasdaq: DTIL) (“Precision”) through the application of its proprietary...